Authors



Jing Wu

Latest:

Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health Outcomes

Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.


Shay Roth, BSPS

Latest:

Empower Prospective Pharmacists through Children’s Books

This short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.


Ryan Haumschild, PharmD, MS, MBA

Latest:

Key Takeaways on mBC and eBC

Key opinion leaders (KOLs) provide key takeaways on metastatic breast cancer and early breast cancer, emphasizing the enthusiasm surrounding recent advances in the field and the potential for improved patient outcomes.


Andres Moreno

Latest:

Infusion Centers Must Be Proactive to Reduce Risks

There are several key areas of risk that infusion practices are likely to face at some point, and proactively preparing for these events can help ensure a positive outcome.


Sam Deutsch, PhD

Latest:

There Is a Need for Better CIN Therapies to Prevent Cervical Cancer

Methods of treating cervical intraepithelial neoplasia are limited and invasive. The need for better treatments is clear; however, there are several promising therapies under development.


Azhar Hussain, DHA, MBA, PharmD Candidate

Latest:

Learning Telehealth Platforms Shows Benefit for Pharmacy Students

Pharmacy graduates must be well-equipped to thrive in various settings, especially in the wake of the pandemic as more avenues to patient care services have emerged.


Matthew Marshall

Latest:

How Stakeholders Can Maximize the Value of Real-World Data Analytics

Analytics allow for a better understanding of the needs of various patient populations and the barriers they face in accessing care.


Oluwaseyi Egbewande, PharmD Candidate

Latest:

The Role of the Pharmacist in Herpes Zoster Vaccination

Pharmacists as immunizers are vaccine distributors, educators, facilitators, and administrators.


Marilyn Bulloch, PharmD, BCPS, FCCM, SPP

Latest:

What Is Going On With Male Contraception?

Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.


Tracey McGrath, PharmD

Latest:

Mindful Art: A Creative Practice Pharmacists Can Use to Reduce Stress

Pharmacists are cited as one of the most stressed professions and a creative habit can help to improve focus, enhance productivity, and reduce stress.


Ashlee Wertman, PharmD

Latest:

The Latest in the Role of Pharmacogenomics in Mental Health Treatment

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.


Raymond Pascual, PharmD candidate

Latest:

Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy

Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.


Addy Howe, PharmD Candidate

Latest:

Hepatitis Awareness Month: Help Your Patients Live(r) Longer

Many of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.


Lynnlee Okda, PharmD

Latest:

HSV Offers Promising Target for Preventive, Therapeutic Vaccines

Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.


Kay Yamamoto, PharmD

Latest:

Avoid Burnout During Times of Uncertainty

Organizations should focus on improving employee well-being and reducing workplace stressors.


Cindy Nguyen, PharmD

Latest:

Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCC

Axitinib, cabozantinib, and lenvatinib are first-line treatment options.


Amy Niles, MBA

Latest:

Alternative Funding Programs Affect Our Most Vulnerable Patient Populations

AFPs limit access to provider-prescribed specialty medications.


Allison Kupsh, PharmD

Latest:

Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical Cancer

Approval of a novel antibody-drug conjugate ushers in new second-line option.


Erin Hunter, Associate Editor

Latest:

Can Smoking and Its Resulting Carbon Monoxide Exposure Improve Cancer Treatment Outcomes?

Smoking increases exposure to carbon monoxide, and this may be associated with better clinical response to autophagy inhibitors.


Paige Clark, RPh

Latest:

Community Pharmacies May Benefit From Embracing AI for Enhanced Profitability

Artificial intelligence (AI) may optimize cash pricing strategies in community pharmacies.


Ayaaz Hussain Khan, PhD

Latest:

Navigating Data Integrity for Generic Drug Approvals

Continuous innovation is required in various technological aspects to effectively manage the challenges of vast clinical data.


Keith Wellman, PharmD, BCPS, MBA

Latest:

Multiple Myeloma Pipeline Offers Promising New Options for Treatment

Novel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.


Amber Suthers, CPhT, MSAH, and Beth Bryan, PharmD

Latest:

Pharmacy Is Ready to Embrace Expanded Roles

Pandemic allows technicians to shine and be increasingly viewed as key to streamlining workflow.


Gauri Sabnis, PhD

Latest:

Case Study: Insulin Sensitizers as Enhancers in Diabetes Management

The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.


Shawn Riser Taylor, PharmD, CPP, CDCES

Latest:

Improving Medication Reconciliation Accuracy in a Primary Care Practice

Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.


Gabrielle Ruggiero, PharmD, BCPS

Latest:

Oncology Overview: Tucatinib for Advanced Unresectable or Metastatic HER2-Positive Breast Cancer

Tucatinib is indicated to treat adults with advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer who have already received at least 1 anti-HER2-based regimen in the metastatic setting.


Allison T. Rhoads, PharmD

Latest:

Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical Cancer

Studies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.



Derek Grimm, PharmD, BCPS

Latest:

Modernizing Health Care With Digiceuticals

Explore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.